Zolgensma’s Price And Its 'Cure One, Cure Many' Potential & Concerts Accessibility - a podcast by SMA News Today

SMA News Today’s Director of Multichannel Content, Michael Morale, discusses an interview where researchers talk about Zolgensma’s price, and its cure one, cure many potential. Also, Community Development Manager Kevin Schaefer reads from the latest 31 Days of SMA story. This post focuses on concert accessibility.

Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today